A Tale of 2 Studies: Study Design and Our Understanding of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence
Clin Infect Dis
.
2021 Nov 2;73(9):e3124-e3126.
doi: 10.1093/cid/ciaa1868.
Authors
Ross M Boyce
1
,
Bonnie E Shook-Sa
2
,
Allison E Aiello
3
Affiliations
1
Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
2
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
3
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
PMID:
33338219
PMCID:
PMC7799336
DOI:
10.1093/cid/ciaa1868
No abstract available
Keywords:
COVID-19; coronavirus; epidemiology; seroprevalence.
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Antibodies, Viral
COVID-19*
Humans
SARS-CoV-2*
Seroepidemiologic Studies
Substances
Antibodies, Viral
Grants and funding
P2C HD050924/HD/NICHD NIH HHS/United States
P30 AG066615/AG/NIA NIH HHS/United States
K23AI141764/NH/NIH HHS/United States